{
    "eid": "2-s2.0-85016184657",
    "title": "Immunogenicity and safety of quadrivalent human papillomavirus types 6/11/16/18 recombinant vaccine in chronic kidney disease stage IV, v and VD",
    "cover-date": "2017-01-01",
    "subject-areas": [
        {
            "$": "Nephrology",
            "@code": "2727"
        },
        {
            "$": "Transplantation",
            "@code": "2747"
        }
    ],
    "keywords": [
        "Cancer",
        "CKD",
        "HPV vaccine"
    ],
    "authors": [
        "Kearkiat Praditpornsilpa"
    ],
    "citedby-count": 6,
    "ref-count": 24,
    "ref-list": [
        "The viral etiology of cervical cancer",
        "HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women",
        "Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis",
        "Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students",
        "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008",
        "Cancer in patients on dialysis for end-stage renal disease: An international collaborative study",
        "Cancer incidence before and after kidney transplantation",
        "Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16: A 2-year randomized controlled clinical trial",
        "Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions",
        "Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials",
        "Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials",
        "Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases",
        "The immune system and kidney disease: Basic concepts and clinical implications",
        "Recommendations for preventing transmission of infections among chronic hemodialysis patients.",
        "The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations",
        "Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay",
        "Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18.",
        "Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 L1 capsomers",
        "GARDASIL Product Information",
        "Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas",
        "Chapter 12: Prophylactic HPV vaccines: Underlying mechanisms",
        "A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.",
        "High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up",
        "Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": []
}